The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function: Cell Metabolism
Frontiers | Glucose Transporters in Diabetic Kidney Disease—Friends or Foes?
GLUT1 biological function and inhibition: research advances | Future Medicinal Chemistry
IJMS | Free Full-Text | Metabolomics of Type 1 and Type 2 Diabetes
Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging | International Journal of Oral Science
Übersicht zu Diabetes mellitus
Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors | BMC Molecular and Cell Biology | Full Text
IJMS | Free Full-Text | The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer’s Disease
Pharmacological inhibition of GLUT1 as a new immunotherapeutic approach after myocardial infarction - ScienceDirect
Suppression of diabetic retinopathy with GLUT1 siRNA | Scientific Reports
IFN‐γ/mTORC1 decreased Rab11 in Schwann cells of diabetic peripheral neuropathy, inhibiting cell proliferation via GLUT1 downregulation - Du - 2020 - Journal of Cellular Physiology - Wiley Online Library
IJMS | Free Full-Text | Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury | Arteriosclerosis, Thrombosis, and Vascular Biology
GLUT1 Regulation of the Pro-Sclerotic Mediators of Diabetic Nephropathy | Semantic Scholar
The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent - ScienceDirect
Differential Effects of GLUT1 or GLUT4 Overexpression on Hexosamine Biosynthesis by Muscles of Transgenic Mice* - Journal of Biological Chemistry
Glucose transporters in brain in health and disease | SpringerLink
Reduction of Glut1 in retinal neurons but not the RPE alleviates polyol accumulation and normalizes early characteristics of diabetic retinopathy | bioRxiv
IJMS | Free Full-Text | Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
SGLT inhibitors in management of diabetes - The Lancet Diabetes & Endocrinology